ge.ch
Frontiers | Perspectives on RNA Vaccine Candidates for COVID-19 | Molecular Biosciences
How do mRNA vaccines work? | Covid-19 vaccination explained
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies | Nature
Design und Funktionsweise von mRNA-basierten Impfstoffen zum Schutz vor Infektionskrankheiten (COVID-19-Update) - Trillium GmbH Medizinischer Fachverlag
How mRNA Technology Gave Us the First COVID-19 Vaccines | Time
Will an mRNA vaccine alter my DNA? | Gavi, the Vaccine Alliance
Switzerland offers non-mRNA Covid-19 vaccine alternative - SWI swissinfo.ch
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland - ScienceDirect
BNT162b2 mRNA COVID-19 Vaccine: First Approval | SpringerLink
BNT162b2 mRNA COVID-19 Vaccine: First Approval | SpringerLink
Protection duration after vaccination or infection – Swiss National COVID-19 Science Task Force
4 things about mRNA COVID vaccines researchers still want to find out | Gavi, the Vaccine Alliance
Vaccines | Free Full-Text | SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond | HTML
UK firm to trial T-cell Covid vaccine that could give longer immunity | Vaccines and immunisation | The Guardian
Building a biotech hub: Switzerland focuses on mRNA, CGT and more
Switzerland backs mRNA vaccine for booster jabs - SWI swissinfo.ch
Swiss Medical Weekly - Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran – a clinical case and global pharmacovigilance data
Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients | Journal for ImmunoTherapy of Cancer
Protection duration after vaccination or infection – Swiss National COVID-19 Science Task Force
Vaccines | Free Full-Text | Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans | HTML
Vaccines | Free Full-Text | mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients | HTML
Swiss Medical Weekly - The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination
Swiss biotech innovation: global power and impact through diversity – Swiss Biotech
How vaccine technology, choice and supply work in Switzerland - SWI swissinfo.ch
mRNA Vaccines: Possible Tools to Combat SARS-CoV-2 | SpringerLink
4 things about mRNA COVID vaccines researchers still want to find out | Gavi, the Vaccine Alliance
Pharmaceutics | Free Full-Text | Opportunities and Challenges in the Delivery of mRNA-Based Vaccines | HTML
